ReviewExpert review of anticancer therapy2018

The evolution into personalized therapies in pancreatic ductal adenocarcinoma: challenges and opportunities.

Anteneh A Tesfaye et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.